245 results
Page 3 of 13
8-K/A
EX-10.1
giy58fksbjxd
7 Jun 21
Ocuphire Announces $15 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
4:05pm
8-K/A
EX-4.1
gb2zm5exl24qjdxoj
7 Jun 21
Ocuphire Announces $15 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
4:05pm
8-K
EX-10.1
j8cv94huqweg7m073z
4 Jun 21
Ocuphire Announces $15 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
4:48pm
8-K
EX-4.1
rfjorw1
4 Jun 21
Ocuphire Announces $15 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
4:48pm
S-8
5wml7ig
31 Mar 21
Registration of securities for employees
4:51pm
424B5
lcr4elz517l
11 Mar 21
Prospectus supplement for primary offering
9:19am
424B4
ptbiyll0nbh0jkdya
17 Feb 21
Prospectus supplement with pricing info
7:14am
8-K
EX-4.1
do66ujcr1xn6ii
4 Feb 21
Entry into a Material Definitive Agreement
12:00am
8-K/A
EX-99.3
gwwq4 ogn81tb5ygvrq
30 Dec 20
Financial Statements and Exhibits
5:13pm
S-8
ycvft0d bgpx5
9 Nov 20
Registration of securities for employees
4:51pm
8-K
EX-10.8
dn2ti9 839
6 Nov 20
Ocuphire Pharma Completes Transactions and Begins Trading on Nasdaq as OCUP
9:18am
8-K
EX-3.3
welg95w
6 Nov 20
Ocuphire Pharma Completes Transactions and Begins Trading on Nasdaq as OCUP
9:18am